Ramsay Health Care | RHC - 普通股股本



金融业
股票价格
AUD 54.25
资产
AUD 21.7B
现金及等价物
AUD 784.4M
销售成本
AUD 3.05B
流动资产
AUD 3.56B
流动负债
AUD 3.95B
债务
AUD 12.12B
股息收益率
8.08
EBIT
AUD 541.1M
EBITDA
AUD 1.12B
员工
90K
EPS每股收益
AUD 0.7
股本和储备
AUD 4.79B
销售毛利
AUD 549.95M
债务利息支出
AUD 300.6M
贷款资金
AUD 11.2B
市值
AUD 12.36B
净收入
AUD 152.7M
营业费用
AUD 8.8B
营业利润
AUD 541.1M
普通股股本
AUD 229.93M
PE价格收益
25.59
税前利润
AUD 240.5M
销售收入
AUD 9.24B
销售和管理费用
AUD 5.29B
股票
AUD 404.4M
贸易债权人
AUD 2.02B
应收帐款人
AUD 2.48B


普通股股本 更改 日
Ansell USD 142.94M 885.26M 2025-12
Cochlear AUD 65.4M 1.12B 2025-12
CSL USD 482.13M 93.87M 2025-12
Fisher Paykel Healthcare NZD 586.94M 313.22K 2026-06
Healius AUD 2.6B 100K 2024-12
Integral Diagnostics AUD 335.09M 1.07M 2024-06
Mayne Pharma AUD 81.25M 0 2025-06
Mesoblast USD 1.3B 8.15M 2026-06
Monash IVF AUD 389.63M 117.15M 2025-12
Nanosonics AUD 303.35M 188.61M 2025-12
Polynovo AUD 690.84M 991 2025-12
Ramsay Health Care AUD 229.93M 29.81K 2025-12
Regis Healthcare AUD 302.36M 1.11M 2025-12
ResMed USD 145.04M 621.52K 2026-03
Ryman Healthcare NZD 1.01B 121.36K 2026-06
Sigma Healthcare AUD 11.5B 9.93B 2025-12
Sonic Healthcare AUD 4.15B 467K 2024-12
Summerset NZD 242.36M 152.83M 2025-12
Telix Pharmaceuticals AUD 339.78M 1.01M 2026-06